Kinnevik AB (publ) 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 4:16 pm Purchase | 2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX | Kinnevik AB (publ) | 11,905,668 4.300% | 1,500,000 (+14.42%) | Filing |
| 2023-05-22 4:05 pm Purchase | 2023-05-12 | 13G | Recursion Pharmaceuticals, Inc. RXRX | Kinnevik AB (publ) | 10,405,668 5.600% | 10,405,668 (New Position) | Filing |